Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Jain

Showing results (31-40 of 488) with videos related to

Pageof 49
Sort By:
Biomed Research International|July 19, 2013
Nanocarriers for diagnosis and targeting of breast cancerArun Sharma, Nitin Jain, Rashmi Sareen
Hematology/Oncology Clinics of North America|June 27, 2021
First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?Hua-Jay J Cherng, Nitin Jain
The New England Journal of Medicine|August 22, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLL. ReplyNitin Jain, Varsha Gandhi, William Wierda
Haematologica|February 13, 2025
BCL2 inhibition in adult acute lymphoblastic leukemia: ready for primetime?Nitin Jain, Elias Jabbour, Marina Konopleva
Current Drug Delivery|March 29, 2012
An insight to osmotic drug deliveryRashmi Sareen, Nitin Jain, Deepak Kumar
BMJ Case Reports|January 25, 2013
Plantaris rupture: why is it important?Seema Rohilla, Nitin Jain, Rohtas Yadav
Lung India : Official Organ of Indian Chest Society|February 27, 2025
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 monthsNitin Jain, Divyam Sharma, Nirmal Kumar Jain
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Inhibition of therapeutically important polymerases with high affinity bis-intercalatorsNitin Jain, Subhashree Francis, Simon H Friedman
Protoplasma|December 20, 2022
Overexpression of a rice Tubby-like protein-encoding gene, OsFBT4, confers tolerance to abiotic stressesNitin Jain, Paramjit Khurana, Jitendra P Khurana
Plant Cell Reports|November 27, 2022
AtTLP2, a Tubby-like protein, plays intricate roles in abiotic stress signallingNitin Jain, Paramjit Khurana, Jitendra P Khurana
Pageof 49

Showing results (31-40 of 488) with videos related to

Sort By:
Pageof 49
Biomed Research International|July 19, 2013
Nanocarriers for diagnosis and targeting of breast cancerArun Sharma, Nitin Jain, Rashmi Sareen
Hematology/Oncology Clinics of North America|June 27, 2021
First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?Hua-Jay J Cherng, Nitin Jain
The New England Journal of Medicine|August 22, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLL. ReplyNitin Jain, Varsha Gandhi, William Wierda
Haematologica|February 13, 2025
BCL2 inhibition in adult acute lymphoblastic leukemia: ready for primetime?Nitin Jain, Elias Jabbour, Marina Konopleva
Current Drug Delivery|March 29, 2012
An insight to osmotic drug deliveryRashmi Sareen, Nitin Jain, Deepak Kumar
BMJ Case Reports|January 25, 2013
Plantaris rupture: why is it important?Seema Rohilla, Nitin Jain, Rohtas Yadav
Lung India : Official Organ of Indian Chest Society|February 27, 2025
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 monthsNitin Jain, Divyam Sharma, Nirmal Kumar Jain
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Inhibition of therapeutically important polymerases with high affinity bis-intercalatorsNitin Jain, Subhashree Francis, Simon H Friedman
Protoplasma|December 20, 2022
Overexpression of a rice Tubby-like protein-encoding gene, OsFBT4, confers tolerance to abiotic stressesNitin Jain, Paramjit Khurana, Jitendra P Khurana
Plant Cell Reports|November 27, 2022
AtTLP2, a Tubby-like protein, plays intricate roles in abiotic stress signallingNitin Jain, Paramjit Khurana, Jitendra P Khurana
Pageof 49